4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001417952-26-000002
Chief Executive Officer acquired 1,106 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fried Robert N · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-30 | Grant or award : show line 1 in the form | +1,106 | $2.71 | $2,997 | 1,060,087 | D |
Loading xslF345X06/wk-form4_1783545408.xml…